Moderna
MRNA
#275
Rank
NZ$157.15 B
Marketcap
NZ$393.64
Share price
-0.47%
Change (1 day)
703.69%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -NZ$5.3 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.21 Billion. In 2025 the company made an earning of -NZ$4.9 Billion, an increase over its 2024 earnings that were of -NZ$6.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$5.3 Billion8.2%
2025 -NZ$4.9 Billion-23.03%
2024 -NZ$6.37 Billion-8.22%
2023 -NZ$6.94 Billion-140.65%
2022 NZ$17.05 B-27.81%
2021 NZ$23.61 B-1911.15%
2020 -NZ$1.31 Billion44.7%
2019 -NZ$0.91 Billion28.63%
2018 -NZ$0.71 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.55 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$13.65 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$84.21 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$74.15 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.99 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.29 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA